Location: Home
  • search
  • go
  • Relate News
  • 5/3/2010Pharma Prospects: A Billion Reasons to Invest in China
  • 4/30/2010NDRC to introduce new “Provisions for Drug Prices”
  • 4/30/2010Novo Nordisk expects SFDA approval for new diabetes treatment in 4Q
  • 4/30/2010SinoPharm acquires Dalian Merro Pharma’s distribution business
  • 4/30/2010Abbott launches new diabetic nutrition in China
  • 4/30/2010Large scale survey reveals high prevalence of mental disorders in Chin...
  • 4/30/2010Reports: pharma plant in Zhejiang sickens 1,000 people
  • 4/30/2010Q1/2010 performance of AstraZeneca boosted by emerging markets/China ...
  • 4/30/2010SFDA approves Chi-Med's IND for its oncology drug candidate
  • 4/30/2010Do Emerging Markets Provide the Answer to the Pharmaceutical Industry?...
  • 4/29/2010TB Alliances gains foothold in Asia with joint intiatives
  • 4/29/2010Ernst & Young releases Global Biotechnology Report 2009
  • 4/28/2010Astellas offers Yen 10 million donation to Chinese earthquake victims ...
  • 4/28/2010Shanghai Pharma boosts its stake in Qingdao Guofeng Pharma
  • 4/28/2010Nilimedix enters distribution agreement with SinoPharm
  • 4/28/2010Novartis to expand internal R&D and sales headcount in China
  • 4/28/2010Chen Zhu elected new president of the CMA
  • 4/27/2010Exclusive Interview with RDPAC's Vivian Chen: Observations on the late...
  • 4/27/2010Bayer to boost China growth through more new product launches
  • 4/27/2010NDRC in the process of developing biopharma industry growth plan
  • 4/27/2010Beijing to issue public hospital reform plan in the second half
  • 4/27/2010SinoPharm expands in Chongqing through acquisition of Changye Pharma ...
  • 4/27/2010Low profile couple of Shenzhen Hepalink become the richest Chinese fol...
  • 4/27/2010Shandong Antibiotics to build a new manufacturing center with CNY 3 bi...
  • 4/27/2010Upcoming Event: Clinical Trials International Summit 2010
  • 4/26/2010PPD opens new vaccine research center in Taizhou
  • 4/26/2010Aoxing Pharma and Johnson Matthey Plc forms Chinese JV for narcotics a...
  • 4/26/2010Charles River agrees to acquire Wuxi PharmaTech for US$1.6 billion
  • 4/26/2010Beijing initiates G20 project to boost biopharma industry growth
  • 4/23/2010Asymchem appoints senior technical executives
  • Page:564/719 Total number of articles:21555: [First][<<] [562] [563] [564] [565] [566] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group